These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6314335

  • 1. Naloxone-inaccessible sigma receptor in rat central nervous system.
    Tam SW.
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6703-7. PubMed ID: 6314335
    [Abstract] [Full Text] [Related]

  • 2. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW.
    Eur J Pharmacol; 1985 Feb 12; 109(1):33-41. PubMed ID: 2986989
    [Abstract] [Full Text] [Related]

  • 3. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ, Hazum E, Cuatrecasas P.
    Proc Natl Acad Sci U S A; 1980 Aug 12; 77(8):4469-73. PubMed ID: 6254028
    [Abstract] [Full Text] [Related]

  • 4. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW, West RE, Miller RJ, Dawson G.
    Proc Natl Acad Sci U S A; 1981 Jul 12; 78(7):4309-13. PubMed ID: 6117074
    [Abstract] [Full Text] [Related]

  • 5. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS, Dufau ML, Catt KJ.
    Endocrinology; 1987 Jul 12; 121(1):384-94. PubMed ID: 3036471
    [Abstract] [Full Text] [Related]

  • 6. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays.
    Su TP, Weissman AD, Yeh SY.
    Life Sci; 1986 Jun 16; 38(24):2199-210. PubMed ID: 3012236
    [Abstract] [Full Text] [Related]

  • 7. The binding of kappa- and sigma-opiates in rat brain.
    Wolozin BL, Nishimura S, Pasternak GW.
    J Neurosci; 1982 Jun 16; 2(6):708-13. PubMed ID: 6283040
    [Abstract] [Full Text] [Related]

  • 8. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct 16; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 9. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.
    Compton DR, Bagley RB, Katzen JS, Martin BR.
    Life Sci; 1987 Jun 01; 40(22):2195-206. PubMed ID: 3035304
    [Abstract] [Full Text] [Related]

  • 10. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL.
    J Pharmacol Exp Ther; 1984 Dec 01; 231(3):539-44. PubMed ID: 6094791
    [Abstract] [Full Text] [Related]

  • 11. The effect of two different buffers on the high affinity 3H-ethylketocyclazocine and 3H-SKF10047 binding to guinea pig brain membranes.
    Grynne BH, Maurset AR, Holmen AT, Enger M.
    Acta Pharmacol Toxicol (Copenh); 1984 Mar 01; 54(3):195-200. PubMed ID: 6144235
    [Abstract] [Full Text] [Related]

  • 12. Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors.
    Hiller JM, Simon EJ.
    J Pharmacol Exp Ther; 1980 Sep 01; 214(3):516-9. PubMed ID: 6249910
    [Abstract] [Full Text] [Related]

  • 13. Interaction of [3H](-)-SKF-10,047 with brain sigma receptors: characterization and autoradiographic visualization.
    Zukin SR, Tempel A, Gardner EL, Zukin RS.
    J Neurochem; 1986 Apr 01; 46(4):1032-41. PubMed ID: 3005501
    [Abstract] [Full Text] [Related]

  • 14. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S, Pasternak GW.
    Brain Res; 1982 Sep 23; 248(1):192-5. PubMed ID: 6289993
    [Abstract] [Full Text] [Related]

  • 15. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal mu-, delta- and kappa-opioid receptors.
    Rattan AK, Tejwani GA.
    Pharmacology; 1994 Jan 23; 48(1):30-40. PubMed ID: 8309985
    [Abstract] [Full Text] [Related]

  • 16. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y, Hiller JM, Simon EJ.
    Mol Pharmacol; 1985 Jan 23; 27(1):46-52. PubMed ID: 3965930
    [Abstract] [Full Text] [Related]

  • 17. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
    Tam SW, Cook L.
    Proc Natl Acad Sci U S A; 1984 Sep 23; 81(17):5618-21. PubMed ID: 6147851
    [Abstract] [Full Text] [Related]

  • 18. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS, Dufau ML, Catt KJ.
    Endocrinology; 1987 Dec 23; 121(6):2044-54. PubMed ID: 2824179
    [Abstract] [Full Text] [Related]

  • 19. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov 23; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 20. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Slifer BL, Dykstra LA.
    Life Sci; 1987 Jan 26; 40(4):343-9. PubMed ID: 3027481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.